The Patent Finder

Omnigen Research, LLC

Also on record
Records under this name other than the patents Omnigen Research, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Back to Omnigen Research, LLC

PatentTitleStatus Expires Confidence
US 11,419,888Composition and Method for Promoting Reduction of Heat Stress in Animals
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,555,964Composition and Method for Promoting Reduction of Heat Stress in Animals
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,663,644Augmentation of Titer for Vaccination in Animals
Term ended
Term ended Apr 26, 2026 · High confidence
Term endedTerm ended Apr 26, 2026High confidence
US 8,828,402Augmentation of Titer for Vaccination in Animals
Term ended
Ended no later than Apr 26, 2026 · Low confidence
Term endedEnded no later than Apr 26, 2026Low confidence
US 9,114,129Augmentation of Titer for Vaccination in Animals
Term ended
Ended no later than Apr 26, 2026 · Low confidence
Term endedEnded no later than Apr 26, 2026Low confidence
US 8,236,303Use of BETA-1,3 (4)-Endoglucanohydrolase, BETA-1,3 (4) Glucan, Diatomaceous Earth, Mineral Clay and Glucomannan to Augment Immune Function
Lapsed on the fee record
Ended Aug 7, 2024 · High confidence
Lapsed on the fee recordEnded Aug 7, 2024High confidence
US 8,568,715Use of BETA-1,3 (4)-Endoglucanohydrolase, BETA-1,3 (4)-Glucan, Diatomaceous Earth, Mineral Clay and Glucomannan to Augment Immune Function
Term ended
Term ended Apr 5, 2024 · High confidence
Term endedTerm ended Apr 5, 2024High confidence
US 8,834,868Use of BETA-1,3 (4)-Endoglucanohydrolase, BETA-1,3 (4)-Glucan, Diatomaceous Earth, Mineral Clay and Glucomannan to Augment Immune Function
Term ended
Ended no later than Apr 5, 2024 · Medium confidence
Term endedEnded no later than Apr 5, 2024Medium confidence
US 8,142,798Augmentation of Titer for Vaccination in Animals
Lapsed on the fee record
Ended Mar 27, 2024 · High confidence
Lapsed on the fee recordEnded Mar 27, 2024High confidence
US 9,173,926Use of BETA-1,3 (4)-Endoglucanohydrolase, BETA-1,3 (4)-Glucan, Diatomaceous Earth, Mineral Clay and Glucomannan to Augment Immune Function
Lapsed on the fee record
Ended Nov 3, 2023 · Medium confidence
Lapsed on the fee recordEnded Nov 3, 2023Medium confidence
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited